Back to Services
Pipeline
Pipeline Expansion
Continuous development of new therapies and indications
24
Total Programs
Innovation Pipeline
Advancing the Future of Cell Therapy
Our robust pipeline represents our commitment to continuous innovation. We're developing next-generation therapies to address a broader range of cancers and improve patient outcomes.
8
Preclinical
Early-stage research and development
5
Phase I
Safety and dosage studies
7
Phase II
Efficacy and side effect evaluation
4
Phase III
Large-scale efficacy confirmation
Novel Targets
Exploring new cancer antigens and therapeutic approaches
Combination Therapies
Developing synergistic treatment strategies
Next-Gen Engineering
Advanced cell modification techniques
Pipeline Highlights
Our pipeline strategy focuses on addressing unmet medical needs and expanding the reach of cell therapy to benefit more patients.
- Multiple FDA-approved therapies
- Robust preclinical pipeline
- Strategic partnerships with leading institutions
- Focus on unmet medical needs
- Accelerated development timelines
- Patient-centric trial design
Development Metrics
Total Programs24
Clinical Trials16
FDA Approvals3
Interested in Clinical Trials?
Learn about ongoing clinical trials and how you can participate in advancing cell therapy research